HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma.

Abstract
The arotinoid Ro 15-0778 (temarotene) is a third generation retinoid without a polar end-group. Established, palpable and measurable rat mammary tumours, chemically induced by oral administration of 12 mg/animal 7,12-dimethylbenz[a]anthracene, were treated with Ro 15-0778 as a feed-admix in daily doses of 100 mg/kg for 6 weeks and 200 and 400 mg/kg for 9 weeks. For comparison, tamoxifen (anti-oestrogen) was administered as a feed-admix in doses of 10 and 30 mg/kg/day for 9 weeks. Treatment with Ro 15-0778 resulted in a marked retardation of tumour growth in the groups treated with 100 and 200 mg/kg/day and in partial or even complete tumour regression in the group receiving 400 mg/kg/day. Tamoxifen treatment caused a transient tumour growth inhibition during weeks 1-5 with subsequent re-growth of mammary tumours. Both compounds were generally well tolerated. No signs or symptoms of hypervitaminosis A were noted with Ro 15-0778. One single convulsive attack occurred with 200 mg/kg/day of Ro 15-0778 and 400 mg/kg/day caused occasional convulsions in five out of 11 rats. The present investigation underlines the fact that the arotinoid Ro 15-0778 is not only a chemopreventive agent but also exerts a chemotherapeutic effect on established, chemically induced, mammary carcinomas of the rat.
AuthorsK Teelmann, W Bollag
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 24 Issue 7 Pg. 1205-9 (Jul 1988) ISSN: 0277-5379 [Print] England
PMID3138121 (Publication Type: Journal Article)
Chemical References
  • Retinoids
  • Tamoxifen
  • 9,10-Dimethyl-1,2-benzanthracene
  • temarotene
Topics
  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Female
  • Mammary Neoplasms, Experimental (chemically induced, drug therapy)
  • Rats
  • Rats, Inbred Strains
  • Retinoids (therapeutic use)
  • Tamoxifen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: